International Data Corp. honors 5 AI companies for patient engagement

health it

International Data Corp. highlighted the importance of integrating artificial intelligence into patient engagement by publishing a report on the top five companies using AI to connect with patients.

AI can be used to gather more specific insights about patient health, provide recommendations on next best action and give patients guidance.

Read More…

Five Companies Applying Artificial Intelligence to Patient Engagement Issues Named IDC Innovators

Business Wire

International Data Corporation (IDC) today published an IDC Innovators report profiling five companies that are applying artificial intelligence (AI) to patient engagement in healthcare. The five companies are: Cogitativo, Integra Connect, Jvion, LifeLink, and Medial EarlySign.

Healthcare organizations have been slow to adopt AI as they often lack data management and/or data science skills. However, the use of AI embedded in applications is seeing some success in the market. Because of their expanded data ingestion capability and computational expertise, clients utilizing AI can gain more granular insights into the health of their population, receive recommendations on next best action, and provide guidance to patients during their healthcare journey.

Read More…

Five Companies Applying Artificial Intelligence to Patient Engagement Issues Named IDC Innovators

IDC

International Data Corporation (IDC) today published an IDC Innovators report profiling five companies that are applying artificial intelligence (AI) to patient engagement in healthcare. The five companies are: Cogitativo, Integra Connect, Jvion, LifeLink, and Medial EarlySign.

Healthcare organizations have been slow to adopt AI as they often lack data management and/or data science skills. However, the use of AI embedded in applications is seeing some success in the market. Because of their expanded data ingestion capability and computational expertise, clients utilizing AI can gain more granular insights into the health of their population, receive recommendations on next best action, and provide guidance to patients during their healthcare journey.

Read More…

More Savings Are Possible for Oncology Care Model, ASCO Study Says

AJMC Biosimilars

A real-world study of patients with breast cancer who received febrile neutropenia prophylaxis with biosimilar pegfilgrastim (Udenyca) or reference pegfilgrastim (Neulasta) has not only demonstrated comparable efficacy between the 2 products but also shown that large-scale comparisons of this nature can be done, according to a study presented at ASCO20 Virtual, the annual meeting of the American Society of Clinical Oncology.

Read More…

Payments on the Fast Track

AMGA - Specialists Front and Center By Charles Saunders, M.D.

For years, the healthcare provider revenue cycle exhibited a degree of financial predictability amid constant industry change. While there have been major challenges, including the rise of Meaningful Use, the shift to the International Classification of Diseases (ICD)-10, and increasing scrutiny by payers regarding medical necessity, an organization's fundamental revenue cycle marching orders have remained consistent: improve the amount and speed of collections while identifying and minimizing payer denials.

Read More…

Integra Connect: RWE can bolster clinical trials

Outsourcing Pharma

Outsourcing-Pharma (OSP) spoke with Hinco Gierman (HG), vice president of product development and scientific insights with Integra Connect, about the use of RWD and RWE throughout the pharmaceutical industry. The discussion talked about intelligent analysis of RWD, and how RWE can effectively supplement clinical trials.

Read More…

How Can Value-Based Care Embrace the Possibilities of Biosimilars?

AJMC Biosimilars

As the healthcare delivery model transitions from a fee-for-service (FFS) model to a value-based model, biosimilars may begin to play a much larger role.

The American healthcare system has largely operated under the FFS model, but a value-based model places more emphasis on cost-saving practices when clinically appropriate and using less-expensive alternatives to branded medications.

Read More…

Data Analytics Improving Care Coordination Programs

managed healthcare executive

West Palm Beach, Florida-based Integra Connect, which develops information technology solutions for healthcare providers, has tracked the performance of its customers involved in the OCM program, which totals about 16 practices and 1,000 oncologists. “What we see is a steady improvement,” says Charles Saunders, MD, CEO, Integra Connect. With each successive performance period, more of the practices have kept their actual costs of care under the target cost set by CMS, he says.

Read More…

Partnership Seeks to Offer Combined Somatic, Germline Testing to Guide Cancer Treatment

AJMC - Managed Markets Network

A new partnership between leading precision medicine companies seeks to give patients with cancer—and their physicians—the most complete look possible at their disease by evaluating both the molecular and genetic elements.

Caris Life Sciences, a leader in somatic testing on cancer tumor cells, has joined forces with Ambry Genetics to offer its 67-gene test that evaluates a patient’s hereditary risk for cancer.

Read More…